Different receptor subtypes are involved tn the serotonin-induced modulation of epileptiform activity in rat frontal cortex in vitro

被引:0
|
作者
Bobula, B [1 ]
Zahorodna, A [1 ]
Bijak, M [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Physiol, Krakow, Poland
来源
关键词
5-HT; 5-HT1A receptors; 5-HT2; receptors; 5-HT1B receptors; 5-HT4 receptors cortical slice; synchronous activity;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The frontal cortex is innervated by serotonergic terminals from The raphe nuclei and it expresses diverse 5-HT receptor subtypes. We investigated the effects of 5-HT and different 5-HT receptor subtype-selective agonists on spontaneous discharges which had developed in rat cortical slices perfused with a Mg2+-free medium and the GABA(A) receptor antagonist picrotoxin. The frequency of synchronous discharges, recorded extracellularly in superficial layers (II/III) of the frontal cortex, was dose-dependently enhanced by 5-HT (2.5-40 muM). That excitatory effect was blocked by the 5-HT2 receptor selective antagonist ketanserin. The 5-HT2A/2C receptor-selective agonist DOI and the 5-HT4 receptor agonist zacopride also increased the frequency of spontaneous discharges. In the presence of ketanserin, 5-HT decreased the discharge rate; a similar effect was observed when the 5-HT1A receptor agonist 8-OH-DPAT or the 5-HT1B receptor agonist CGS-12066B was applied. The 5-HT3 receptor agonist m-CPBG was ineffective. In conclusion, 5-HT produces multiple effects on epileptiform activity in the frontal cortex via activation of various 5-HT receptor subtypes. The excitatory action of 5-HT, which predominates, is mediated mainly by 5-HT2 receptors. The inhibitory effects can be attributed to activation of 5-HT1A and 5-HT1B receptors.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 46 条
  • [1] Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes
    Bijak, M
    NEUROSCIENCE LETTERS, 1999, 268 (03) : 115 - 118
  • [2] 5-HT RECEPTOR SUBTYPES INVOLVED IN LUMINAL SEROTONIN-INDUCED SECRETION IN RAT INTESTINE IN-VIVO
    HANSEN, MB
    JAFFE, BM
    JOURNAL OF SURGICAL RESEARCH, 1994, 56 (03) : 277 - 287
  • [3] RECEPTOR SUBTYPES INVOLVED IN CALLOSALLY-INDUCED POSTSYNAPTIC POTENTIALS IN RAT FRONTAL AGRANULAR CORTEX INVITRO
    KAWAGUCHI, Y
    EXPERIMENTAL BRAIN RESEARCH, 1992, 88 (01) : 33 - 40
  • [4] Serotonin blocks different patterns of low Mg2+-induced epileptiform activity in rat entorhinal cortex, but not hippocampus
    Schmitz, D
    Empson, RM
    Gloveli, T
    Heinemann, U
    NEUROSCIENCE, 1997, 76 (02) : 449 - 458
  • [5] Neuropeptide Y suppresses epileptiform activity and excitatory synaptic transmission in rat frontal cortex in vitro.
    Bijak, M
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 48 - 48
  • [6] Anticholinesterase-induced epileptiform activity in immature rat piriform cortex slices, in vitro
    Aitchison, Eleanor
    Weston, Samantha E.
    Constanti, Andrew
    Whalley, Benjamin J.
    NEUROSCIENCE LETTERS, 2010, 473 (03) : 252 - 256
  • [7] 5-HT receptor subtypes involved in the serotonin-induced inhibition of L-leucine absorption in rabbit jejunum
    Salvador, MT
    RodriguezYoidi, MC
    Alcalde, AI
    RodriguezYoldi, MJ
    LIFE SCIENCES, 1997, 61 (03) : 309 - 318
  • [8] Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus
    Damjanoska, KJ
    Heidenreich, BA
    Kindel, GH
    D'Souza, DN
    Zhang, Y
    Garcia, F
    Battaglia, G
    Wolf, WA
    Van de Kar, LD
    Muma, NA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03): : 1043 - 1050
  • [9] SEROTONIN-INDUCED SMALL-BOWEL INFLAMMATION AND MOTOR-ACTIVITY - SITES OF ACTION AND RECEPTOR SUBTYPES IN-VIVO
    GRAF, S
    SARNA, SK
    FINK, J
    HENDERSON, JD
    GASTROENTEROLOGY, 1994, 106 (04) : A506 - A506
  • [10] Evidence that GABA, serotonin, and norepinephrine are involved in the modulation of in vitro rhythmical activity in rat hippocampal slices
    Boguszewicz, J
    Skrajny, B
    Kohli, J
    Roth, SH
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (12) : 1322 - 1326